July 2026
The global particle therapy market size is expected to increase from USD 1.86 billion in 2025 to hit around USD 3.92 billion by 2035, growing at a CAGR of 7.75%.
September 2026
The U.S. brachytherapy market was worth USD 370.79 million in 2026, with key U.S. brachytherapy market players including Becton Dickinson & Co, Eckert & Ziegler Bebig SA, Elekta AB ADR.
September 2026
The global radioimmunotherapy market size was evaluated at USD 3.65 billion in 2026 and is expected to attain around USD 14.36 billion by 2035, with a CAGR of 16.46%.
September 2026
The global nanoparticle synthesis system market size was estimated at USD 1.88 billion in 2026 and is expected to hit around USD 4.19 billion by 2034, growing at a CAGR of 10.54%.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
September 2026
The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.
September 2026
The global compression therapy market size is expected to worth around USD 9.44 billion by 2035, increasing from USD 5.49 billion in 2026 with a CAGR of 6.21%.
September 2026
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
September 2026
The cryotherapy market was valued at USD 11.18 billion in 2026, with leading companies including Brymill Cryogenic Systems, Metrum Cryoflex, Medtronic plc.
September 2026
The nicotine replacement therapy market generated USD 108.61 billion in 2026, with prominent nicotine replacement therapy companies including Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Glenmark Pharmaceuticals.
August 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
August 2026
The continuous renal replacement therapy market size was USD 1.71 billion in 2026, with leading continuous renal replacement therapy market players including baxter international inc, nikkiso co. ltd, infomed sa, Medtronic plc, bellco.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
August 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
August 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
August 2026
The home infusion therapy market size was valued at USD 41.83 billion in 2025 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
July 2026
The global cardiac resynchronization therapy market size is projected to hit around USD 18.33 billion by 2035 from USD 9.05 billion in 2025 with a CAGR of 7.31%.
July 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.47 billion in 2025 with a notable CAGR of 5.66%.
July 2026
The global hormone replacement therapy market size is projected to hit around USD 70.63 billion by 2035 from USD 39.64 billion in 2025 with a notable CAGR of 5.95%.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The global radioligand therapy market size is estimated to hit around USD 36.47 billion by 2035 increasing from USD 3.20 billion in 2025, with a CAGR of 27.55%.
July 2026
The global radiation therapy market size was estimated at USD 8.15 billion in 2025 and is expected to hit around USD 19.29 billion by 2035 with a CAGR of 9%.
July 2026
The cell and gene therapy patient access and reimbursement market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com